Article Abstract:
The Celera Genomics Group which had a database subscription business for pharmaceutical companies and academic institutions is transforming itself into a drug development company, giving its original business to sister company Applied Biosystems. Shares are suitable only to speculative investors.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
A comparative analysis of the company sales and the financial details of RPM International from 1988 to 2003 are illustrated. Projections of the annual total returns, revenues and asset position of the company for the period 2007-09 are made using Value Line estimates.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
RPM International Inc. is concerned about asbestos related claims from the Bondex automotive maintenance unit and has affected the earnings considerably. Investors are advised to wait until the risky liability issue eases or is resovled.
User Contributions:
Comment about this article or add new information about this topic: